Continuing Medical Education Information
AACE Endocrine University
Event start date: 02/2/2023
Credit claim deadline: 12/31/2023
Statement of Need
Endocrine University® is designed to provide a forum for endocrinology fellows -in-training to enhance their endocrine curriculum, particularly in diabetes, thyroid, bone, and new technology which has become essential to the practice of endocrinology.
Target Audience:
This program is intended for first year Endocrine Fellows-in-Training.
Learning Objectives
By the end of the meeting, participants will be able to:
- Effectively utilize new skills and technology in diabetes and thyroid ultrasound.
- Apply the most up-to-date guidelines and evidence-based practices for the diagnosis and treatment of diabetes and thyroid disease.
- Integrate the latest evidence-based research for diagnosis and treatment of emerging areas of diabetes, thyroid, and bone related practice.
Accreditation and Designation Statements
The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Endocrinology (ACE) designates this other (live virtual) activity for a maximum of 16 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure and Conflicts of Interest Policy:
The American Association of Clinical Endocrinology (AACE) remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of AACE to eliminate all situations of potential conflict of interest, but rather to enable those who are working with AACE to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the CME Subcommittee to ensure that such situations are properly evaluated and, if necessary, resolved. AACE educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all AACE accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.
Commercial Support
This activity is supported by educational grants from the following:
- Abbott Diabetes Care
- Amgen
- Corcept Therapeutics
- Dexcom, Inc.
- Lilly USA, LLC
- Merck-Pfizer Diabetes Collaboration
- Novo Nordisk
- Recordati Rare Diseases
- Rhythm Pharmaceuticals
- Sandoz, Inc.
- Ultragenyx Pharmaceutical
Planning Committee
- Sara E. Lubitz, MD, FACE
- Matthew J. Levine, MD, FACE
- David Lieb, MD, FACP, FACE
- Michelle Lundholm, MD
- Pooja Luthra, MD, FACE
- Jawairia Shakil, MBBS
- Dace Trence, MD, MACE
- Geetha Gopalakrishnan, MD
- Sarah Mayson, MD
Planning Committee Disclosures
Planner Name
Sara E. Lubitz, MD, FACE
Ineligible Company
Hologic
Zealand Pharma
Eli Lilly
Takeda
Amryt
Relevant Financial Relationship
Stock Ownership
Stock Ownership
Stock Ownership
Site PI Research Funding
Site PI Research Funding
Planner Name
Matthew J. Levine, MD, FACE
Ineligible Company
Eli Lilly
Mannkind
Novo Nordisk
APDEM
Relevant Financial Relationship
Speakers Bureau
Consultant
Speakers Bureau
BOD/EC
Planner Name
David Lieb, MD, FACP, FACE
Ineligible Company
ADA Hampton Roads
APDEM
Endocrine Society
Mid Atlantic Society of Endocrinologists
Relevant Financial Relationship
Leadership Council
Leadership Council
Guideline/Paper; Co-Chair Diabetes and Hypoglycemia Clinical Practice Guideline
Secretary, Treasurer, Board member
Planner Name
Pooja Luthra, MD, FACE
Ineligible Company
APDEM
Relevant Financial Relationship
Co-Chair of Health Equity Subcommittee
Planner Name
Dace Trence, MD, MACE
Ineligible Company
Medtronic
Sanofi
Relevant Financial Relationship
Stock Ownership
Stock Ownership
Planner Name
Sarah Mayson, MD
Ineligible Company
ATA
Endocrine Society ESAP
Relevant Financial Relationship
Guideline/Paper
ABIM/ABOM
Faculty Disclosures
Faculty Name
David Ahn, MD
Ineligible Company
Ascensia Diabetes Care
Lilly Diabetes
Mannkind
Novo Nordisk
Roche Diagnostics
Xeris Pharmaceuticals
Relevant Financial Relationship
Advisory Board
Advisory Board; Speakers Bureau
Advisory Board
Speakers Bureau
Advisory Board
Speakers Bureau
Faculty Name
Ashok Balasubramanyam, MD
Ineligible Company
Chair of the ABIM Endocrinology, Metabolism and Diabetes Board; Councilor of the American Board of Internal Medicine
Relevant Financial Relationship
BOD/EC
Faculty Name
Maria Cabanillas, MD, FACE
Ineligible Company
Bayer
Exelixis
Relevant Financial Relationship
Consultant; Speaker
Advisory Board
Faculty Name
Mimi Hu, MD
Ineligible Company
ATA
Blueprint Medicines
Eli Lilly
Endocrine Society
Medical Education Resources
Targeted Oncology
Relevant Financial Relationship
Guideline/Paper
Advisory Board; Consultant
Consultant; Site PI Research funding
Guideline/Paper
Speaker Bureau
Speaker Bureau
Faculty Name
Silvio Inzucchi, MD
Ineligible Company
Abbott
AstraZeneca
Boehringer-Ingelheim
Esperion
Lexicon
Merck/Pfizer
Novo Nordisk
VTV Therapeutics
Relevant Financial Relationship
Consultant
Consultant
Consultant
Consultant
Consultant
Consultant
Consultant
Consultant
Faculty Name
Michael Lewiecki, MD, FACE
Ineligible Company
Amgen
Osteoporosis Foundation of New Mexico
Radius
Relevant Financial Relationship
Consultant, Investigator, Speaker
BOD/EC
Investigator
Faculty Name
Debra Margulies, MD, ECNU, FACE
Ineligible Company
ATA
Relevant Financial Relationship
Clinical Affairs Committee, Chair-Elect 2023
Faculty Name
Nadine Palermo, DO
Ineligible Company
Dexcom
Relevant Financial Relationship
Research support
Faculty Name
Elizabeth Pearce, MD, MSc, FACE
Ineligible Company
American Thyroid Association
Iodine Global Network
National Dairy Council
Relevant Financial Relationship
Member of thyroid in pregnancy guidelines task force; Co-Chair of Centennial task force
Management Council
Consultant
Faculty Name
Steven Petak, MD, JD, MACE, FACP
Ineligible Company
Alexion
Amgen
Relevant Financial Relationship
Speaker Bureau
Speaker Bureau
Faculty Name
Richard Pratley, MD
Ineligible Company
Bayer AG
Corcept Therapeutics Inc.
Dexcom
Gasherbaum Bio, Inc.
Hanmi Pharmaceutical Co.
Hengrui (USA) Ltd.
Merck
Metavention
Novo Nordisk
Pfizer
Rivus Pharmaceuticals Inc.
Sanofi
Scohia Pharma Inc.
Sun Pharmaceutical Industries
Relevant Financial Relationship
Consultant
Consultant
Consultant
Consultant
Consultant
Consultant
Consultant
Research Funding
Research Funding/Consultant
Consultant
Consultant
Consultant
Consultant
Consultant
Faculty Name
Archana Sadhu, MD, FACE
Ineligible Company
Abbott Laboratories
Primed
Relevant Financial Relationship
Consultant
Honoraria less than 10,000 per year
Faculty Name
Elias Siraj, MD, FACE, FACP
Ineligible Company
Boehringer-Ingelheim/Eli Lilly alliance
Novo Nordisk
Relevant Financial Relationship
Speaker Bureau Speaker; Research Funding
Faculty Name
Robert Stanton, MD
Ineligible Company
Professional Practice Committee of the American Diabetes Association
Relevant Financial Relationship
BOD/EC
Faculty Name
Guillermo Umpierrez, MD, MACP, CDCES, FACE
Ineligible Company
Abbott
American Diabetes Association
AstraZeneca
Bayer
Dexcom
Relevant Financial Relationship
Research Funding
BOD/EC
Research Funding
Research Funding
Research Funding
All of the relevant financial relationships listed for these individuals have been mitigated. All other faculty for this educational activity have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Reviewers
None of the reviewers for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.